Work

312 (PB300): Concurrent inhibition of KRAS G12C and ERK1/2 overcomes acquired resistance to KRAS G12C inhibitors (G12Cis) conferred by various genetic alterations

Year: 2024

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2024.114825

Authors: W. Wang, S.M. Lim, M.R. Yu, B.C. Cho, C. Chen, W. Wu, J. Zhang, Z.J. Chen, Y.L. Wu

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403748805

FWCI:

Cites:

Cited by:

Related to: 10